A lymphoma cell line resistant to 4-piperidinopiperidine was less sensitive to CPT-11 Y. OnishiMasao OguroHarutoshi Kizaki ORIGINAL ARTICLE Pages: 473 - 478
Response of sensitive and resistant IgM immunocytomas to cis-diamminedichloroplatinum(II) does not correlate with the platination level or with the formation or removal of DNA adducts Cornelis P. J. VendrikAnne Marie J. Fichtinger-SchepmanP. A. Steerenberg ORIGINAL ARTICLE Pages: 479 - 485
Preclinical antitumor activity of water-soluble paclitaxel derivatives William C. RoseJohn L. ClarkAnna Maria Casazza ORIGINAL ARTICLE Pages: 486 - 492
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers David S. AlbertsPaul T. FantaSydney E. Salmon ORIGINAL ARTICLE Pages: 493 - 497
Isolation and structural confirmation of N-desmethyl topotecan, a metabolite of topotecan H. RosingV. M. M. HerbenJ. H. Beijnen ORIGINAL ARTICLE Pages: 498 - 504
Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the rat B. J. CusackStephan P. YoungRichard D. Olson ORIGINAL ARTICLE Pages: 505 - 512
Tissue distribution of transdermal toremifene L. SoeGregory T. WurzM. W. DeGregorio ORIGINAL ARTICLE Pages: 513 - 520
Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytostasis John L. TonkinsonPhilip MarderL. G. Mendelsohn ORIGINAL ARTICLE Pages: 521 - 531
Preclinical pharmacokinetics of β-L-dioxolane-cytidine, a novel anticancer agent, in rats Laura E. MooreF. D. BoudinotChung K. Chu ORIGINAL ARTICLE Pages: 532 - 536
Adrenal proteins bound by a reactive intermediate of mitotane W. CaiRaymond E. CounsellLinda L. Wotring ORIGINAL ARTICLE Pages: 537 - 540
Mechanisms of enhancement of the antitumour activity of melphalan by the tumour-blood-flow inhibitor 5,6-dimethylxanthenone-4-acetic acid Frederik B. PruijnM. van DaalenW. R. Wilson ORIGINAL ARTICLE Pages: 541 - 546
High-dose toremifene in advanced renal-cell carcinoma Michael M. GershanovichVladimir M. MoiseyenkoMarkku Anttila CLINICAL TRIAL REPORT Pages: 547 - 551
Interference by antifolate drugs in a folate competitive protein-binding assay Anthea HardcastleStephen ClarkeW. Aherne SHORT COMMUNICATION Pages: 552 - 553
Pharmacokinetics and tissue distribution of idarubicin and its active metabolite idarubicinol in the rabbit M. LoobyR. LinkeM. Weiss SHORT COMMUNICATION Pages: 554 - 556
Plasma concentrations of polysorbate 80 measured in patients following administration of docetaxel or etoposide L. K. WebsterMartha E. LinsenmeyerMichael J. Millward SHORT COMMUNICATION Pages: 557 - 560
Effect of ifosfamide on intracellular glutathione levels in peripheral blood lymphocytes and its correlation with therapeutic response in patients with advanced ovarian cancer I. A. MalikNaseema MehboobaliM. Perwaiz Iqbal SHORT COMMUNICATION Pages: 561 - 565